David Murphy

Dr. David Murphy


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2024 in European Radiology
Verified
Journal Article
Open access
PDF file
RDRyan Donnelly
Ryan Donnelly
MMMichael McDermott
Michael McDermott
GMGerry McManus
Gerry McManus
AFAlessandro N. Franciosi
Alessandro N. Franciosi
MKMichael P. Keane
Michael P. Keane
DMDavid Murphy
David Murphy
Background: 18F-Fluorodeoxyglucose (FDG) PET/CT is emerging as a tool in the diagnosis and evaluation of pulmonary sarcoidosis, however, there is limited consensus regarding its diagnostic performance and prognostic value. Method: A meta-analysis was conducted with PubMed, Science Direct, MEDLINE, Scopus, and CENTRAL databases searched up to and including September 2023. 1355 studies were screened, with seventeen (n = 708 patients) suitable based on their assessment of the diagnostic performance or prognostic value of FDG-PET/CT. Study quality was assessed using the QUADAS-2 tool. Forest plots of pooled sensitivity and specificity were generated to assess diagnostic performance. Pooled changes in SUVmax were correlated with changes in pulmonary function tests (PFT). Results: FDG-PET/CT in diagnosing suspected pulmonary sarcoidosis (six studies, n = 400) had a pooled sensitivity of 0.971 (95%CI 0.909–1.000, p = < 0.001) and specificity of 0.873 (95%CI 0.845–0.920)(one study, n = 169). Eleven studies for prognostic analysis (n = 308) indicated a pooled reduction in pulmonary SUVmax of 4.538 (95%CI 5.653–3.453, p = < 0.001) post-treatment. PFTs displayed improvement post-treatment with a percentage increase in predicted forced vital capacity (FVC) and diffusion capacity of the lung for carbon monoxide (DLCO) of 7.346% (95%CI 2.257–12.436, p = 0.005) and 3.464% (95%CI -0.205–7.132, p = 0.064), respectively. Reduction in SUVmax correlated significantly with FVC (r = 0.644, p < 0.001) and DLCO (r = 0.582, p < 0.001) improvement. Conclusion: In cases of suspected pulmonary sarcoidosis, FDG-PET/CT demonstrated good diagnostic performance and correlated with functional health scores. FDG-PET/CT may help to guide immunosuppression in cases of complex sarcoidosis or where treatment rationalisation is needed. Clinical relevance statement: FDG-PET/CT has demonstrated a high diagnostic performance in the evaluation of suspected pulmonary sarcoidosis with radiologically assessed disease activity correlating strongly with clinically derived pulmonary function tests. Key Points: In diagnosing pulmonary sarcoidosis, FDG-PET/CT had a sensitivity and specificity of 0.971 and 0.873, respectively. Disease activity, as determined by SUVmax, reduced following treatment in all the included studies. Reduction in SUVmax correlated with an improvement in functional vital capacity, Diffusion Capacity of the Lungs for Carbon Monoxide, and subjective health scoring systems.

1 June 2019 in European Journal of Radiology
Verified
Journal Article
Closed access
DMDavid Murphy
David Murphy
SMS.M. Mak
S.M. Mak
AMA. Mallia
A. Mallia
SJS. Jeljeli
S. Jeljeli
JSJ.J. Stirling
J.J. Stirling
Gary John Russell CookGary John Russell Cook
Gary John Russell Cook

6 May 2020 in British Journal of Radiology
Verified
Journal Article
Closed access
SLStephen Liddy
Stephen Liddy
AMAndrew Mallia
Andrew Mallia
CCConor D Collins
Conor D Collins
RKRonan P Killeen
Ronan P Killeen
SSStephen Skehan
Stephen Skehan
DMDavid Murphy
David Murphy
Since its introduction into clinical practice, 2-deoxy-2-[18F]flu-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT) has become firmly established in the field of oncological imaging, with a growing body of evidence demonstrating its use in infectious and inflammatory vascular pathologies. This pictorial review illustrates the utility of FDG PET/CT as a diagnostic tool in the investigation of vascular disease and highlights some of the more common incidental vascular findings that PET reporters may encounter on standard oncology FDG PET/CTs, including atherosclerosis, large vessel vasculitis, complications of vascular grafts, infectious aortitis and acute aortic syndromes.

1 August 2019 in European Journal of Radiology
Verified
Journal Article
Closed access
DMDavid Murphy
David Murphy
LRL. Royle
L. Royle
ZCZ. Chalampalakis
Z. Chalampalakis
LAL. Alves
L. Alves
NMN. Martins
N. Martins
MSM. Subesinghe
M. Subesinghe

1 August 2014 in European Journal of Radiology
Verified
Journal Article
Closed access
DMDavid Murphy
David Murphy
SMSinead H. McEvoy
Sinead H. McEvoy
SISri Iyengar
Sri Iyengar
GFGudrun Feuchtner
Gudrun Feuchtner
RCRicardo C. Cury
Ricardo C. Cury
JDJonathan D. Dodd
Jonathan D. Dodd

1 January 2018 in Journal of Medical Artificial Intelligence
Verified
Journal Article
Open access
PDF file
DMDavid Murphy
David Murphy
ABAndrea Bille
Andrea Bille